JohnByronPattersonMD

PubMed

• Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer.
  Zhao, N.,Cao, J.,Xu, L.,Tang, Q.,Dobrolecki, L. E.,Lv, X.,Talukdar, M.,Lu, Y.,Wang, X.,Hu, D. Z.,Shi, Q.,Xiang, Y.,Wang, Y.,Liu, X.,Bu, W.,Jiang, Y.,Li, M.,Gong, Y.,Su...> ;J. Clin. Invest.. 2018 Feb 27
• Potent and Selective Inhibitors of the Inositol-requiring Enzyme 1 Endoribonuclease.
  Volkmann, K., Lucas, J.L., Vuga, D., Wang, X., Brumm, D., Stiles, C., Kriebel, D., Der-Sarkissian, A., Krishnan, K., Schweitzer, C., Liu, Z., Malyankar, U.M., Chiovitt...> ;J Biol Chem. 2011 Apr 8
• Vascular responses to the multiple overlapped paclitaxel-eluting stents for the treatment of bare-metal in-stent restenotic lesions: angiographic and intravascular ult...
  Koizumi, T., Fitzgerald, P.J., Honda, Y., Ellis, S.G., Kent, K., Martin, S.L., Brown, C.L., Masud, A.Z., Patterson, J.B., Greenberg, J., Friedman, M., Uchida, T., Ston...> ;Cardiovasc Revasc Med. 2010-07-01
• Stress chaperone GRP78/BiP confers chemoresistance to tumor-associated endothelial cells.
  Virrey, J. J., Dong, D., Stiles, C., Patterson, J. B., Pen, L., Ni, M., Schönthal, A. H., Chen, T. C., Hofman, F. M., Lee, A. S.> ;Mol Cancer Res. 2008 Aug
• Vascular targeting and antiangiogenesis agents induce drug resistance effector GRP78 within the tumor microenvironment.
  Dong, D.,Ko, B.,Baumeister, P.,Swenson, S.,Costa, F.,Markland, F.,Stiles, C.,Patterson, J. B.,Bates, S. E.,Lee, A. S.> ;Cancer Res. 2005 Jul 1
• Functionally distinct double-stranded RNA-binding domains associated with alternative splice site variants of the interferon-inducible double-stranded RNA-specific ade...
  Liu, Y., George, C. X., Patterson, J. B., Samuel, C. E.> ;J Biol Chem. 1997 Feb 14
• Join now to see all